We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cycloplegic Delivery Investigation

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00472524
First Posted: May 11, 2007
Last Update Posted: July 3, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Ohio State University
  Purpose
The goal of this study is to compare the effectiveness of the administration of sequential drops, a combination drop and a combination spray for producing mydriasis and cycloplegia.

Condition Intervention
Healthy Procedure: Mydriasis/cycloplegia via different modes of administration

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic

Further study details as provided by Ohio State University:

Estimated Enrollment: 50
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   8 Years to 30 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • patients ages 8 to 30 with best corrected acuity of 20/30 or better in both eyes at distance and near will be recruited.

Exclusion Criteria:

  • vision not correctable to 20/30 or better
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00472524


Sponsors and Collaborators
Ohio State University
Investigators
Principal Investigator: Marjean Kulp, OD, MS Ohio State University
  More Information

ClinicalTrials.gov Identifier: NCT00472524     History of Changes
Other Study ID Numbers: 2003H0072
First Submitted: May 9, 2007
First Posted: May 11, 2007
Last Update Posted: July 3, 2008
Last Verified: July 2008